Register Login
Register to leave comments
  • News bot Jan. 6, 2026, 10:56 p.m.

    🔍 Chacko Jacob (Executive)

    Company: Oric Pharmaceuticals, Inc. (ORIC)

    Report Date: 2026-01-02

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 787,500

    Detailed Transactions and Holdings:

    • Acquired 675,000 shares of Stock Option (right to buy) at $8.17 per share (Derivative)
      Date: 2026-01-02 | Code: A | Expires: 2036-01-01 | equity_swap_involved: 0 | shares_owned_after: 675,000.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 112,500 shares of Restricted Stock Unit (Derivative)
      Date: 2026-01-02 | Code: A | equity_swap_involved: 0 | shares_owned_after: 112,500.00 | transaction_form_type: 4 | Footnotes: F2, F3, F3

    Footnotes:

    • F1: 25% of the shares subject to the option shall vest on January 2, 2027, and 1/36th of the remaining shares subject to the option shall vest each month thereafter.
    • F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. Common Stock.
    • F3: 1/3rd of the RSUs subject to the award shall vest on each of December 15, 2026, December 15, 2027 and December 15, 2028.

Search

News categories